UB
JAZZ icon

UMB Bank’s Jazz Pharmaceuticals JAZZ Stock Holding History

UMB Bank’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$271K Buy
1,123
+368
+49% +$80.6K ﹤0.01% 647
2026
Q1 		$143K Buy
755
+30
+4% +$5.24K ﹤0.01% 813
2025
Q4 		$123K Buy
725
+81
+13% +$12.4K ﹤0.01% 856
2025
Q3 		$84.9K Buy
644
+41
+7% +$4.92K ﹤0.01% 939
2025
Q2 		$64K Sell
603
-70
-10% -$7.6K ﹤0.01% 1025
2025
Q1 		$83.6K Buy
673
+362
+116% +$47.2K ﹤0.01% 845
2024
Q4 		$38.3K Buy
311
+129
+71% +$15.2K ﹤0.01% 1020
2024
Q3 		$20.3K Buy
182
+145
+392% +$15.9K ﹤0.01% 1227
2024
Q2 		$3.95K Buy
37
+12
+48% +$1.32K ﹤0.01% 1519
2024
Q1 		$3.01K Buy
25
+18
+257% +$2.21K ﹤0.01% 1448
2023
Q4 		$861 Sell
7
-264
-97% -$32.9K ﹤0.01% 1541
2023
Q3 		$35.1K Hold
271
– – ﹤0.01% 919
2023
Q2 		$33.6K Hold
271
– – ﹤0.01% 948
2023
Q1 		$39.7K Buy
271
+112
+70% +$16.6K ﹤0.01% 903
2022
Q4 		$25K Buy
159
+152
+2,171% +$22.3K ﹤0.01% 1034
2022
Q3 		$1K Buy
+7
New +$1.06K ﹤0.01% 1671

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

UMB Bank's JAZZ Position: Q2 2026 in Review

UMB Bank increased its Jazz Pharmaceuticals (JAZZ) stake by 49% in Q2 2026, buying an estimated $80.6K and bringing the position to 1,123 shares worth $271K. The position accounts for ﹤0.01% of the portfolio, ranked #647.

UMB Bank first reported a position in JAZZ in Q3 2022 and has held it in 16 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • UMB Bank held 1,123 shares of Jazz Pharmaceuticals worth $271K as of Q2 2026.
  • UMB Bank bought 368 Jazz Pharmaceuticals shares in Q2 2026, an estimated $80.6K.
  • Jazz Pharmaceuticals made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #647 holding.
  • UMB Bank first reported a position in Jazz Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.